Shulamit Ron-Bigger
Chief Operating Officer · Aktis Oncology, Inc.
- 2026
- Jul 10, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Shulamit Ron-Bigger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- Ansbert Gadicke - $20.03M in AKTS purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $20.03M in AKTS purchases and sales in the last 12 months
- Vida Ventures II, LLC - $15.03M in AKTS purchases and sales in the last 12 months
- Helen Susan Kim - $15.03M in AKTS purchases and sales in the last 12 months
- Todd Foley - $4.19M in AKTS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Shulamit Ron-Bigger?
Shulamit Ron-Bigger is a corporate insider, tracked as Chief Operating Officer of Aktis Oncology, Inc. (AKTS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Shulamit Ron-Bigger last file a Form 4?
The only primary Form 4 on record is dated 10 July 2026.
Has Shulamit Ron-Bigger been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.39M) across all tracked filings.
